, Acquisition by RADIOPHARMA Partners of CISBIO (SCHERING, p.2005, 2006.

. Btg-vivasanté, J. Merger-of, E. Bio, and . Urgo, Acquisition by SOLVAY of FOURNIER Pharma, p.2004, 2005.

, Acquisition by BOIRON of DOLISOS, 2004.

. Sanofi-aventis, Acquisition by SANOFI-SYNTHELABO of AVENTIS, 2004.

. Mcneil, Acquisition by STRAKAN of OTL PHARMA (2004) Acquisition by ZENEUS Pharma (ex-MEDEUS) of Opérations Européennes, p.2003, 2004.

, Acquisition by IVAX of Actifs Médicaments de 3M PHARMA (2003) Acquisition by ZYDUS CADILA of french subsidiary of ALPHARMA (2003) Acquisition by ITALFARMACO of EFFIK, Acquisition by RANBAXY of RPG Biogalénique, french subsidiary of Génériques d'AVENTIS, p.2002, 2003.

, Acquisition by MERCK (ex-MERCK-LIPHA) of RICHELET (2002) Acquisition by OMEGA-PHARMA of DELTA, LSBH and BRAMI, 2002.

P. Fabre and E. Bmpf, Acquisition by ZAMBON of Opérations Pharma de LAPHAL (2002) Divorce between BIOMÉRIEUX, becoming SERONO GENETICS INSTITUTE, 2002.

, Acquisition by EISAI of BIODIM, subsidiary of CÉGÉDIM, p.2001, 2002.

, Acquisition by AXCAN PHARMA of ENTÉRIS (2001) Acquisition by CHURCH & DWIGHT of FUMOUZE (2001) Acquisition by ALLMIRAL of PHARMAPHARM, Acquisition by CEPHALON of LAFON, 2001.

. Biomérieux-pierre-fabre, P. Merger, and . Fabre, Acquisition by BIOMÉRIEUX of ORGANON TECNIKA, division Diagnostics of AKZO NOBEL, p.2000, 2001.

J. Acquisition and . France, , 2000.

M. Aventis and H. M. , , 1999.

A. Santé, . Merger, and . Répartition, Acquisition by ALPHARMA of JUMER and THÉRA (1999) Acquisition by MERCK-LIPHA of THÉRAMEX (1999) Acquisition by MERCK-LIPHA of QUALIMED, Hospital Générics (1999) Acquisition by OMEGA-PHARMA of PHARMYGIÈNE (1999) Acquisition by CHIESI of PROMEDICA and LOGEAIS, 1999.

. Sanofi-synthélabo, . Merger, and . Synthélabo, , 1999.

. Merck-lipha, L. Darmstadt-of, and L. Industrielle-pharmaceutique, Acquisition by PIERRE FABRE of DOLISOS, and of LIMAGRAIN (1998) Acquisition by ETHYPHARM of DEXO, p.1997, 1998.

, Acquisition by AMERSHAM of NYCOMED, 1996.

P. M. Merger-between, P. V. Mérieux-s, and . Connaught, Acquisition by HOECHST (43% of Capital restant) of ROUSSEL UCLAF, p.1995, 1996.

, Acquisition by RPR of BIOGALÉNIQUE, société de Génériques (1995) Acquisition by RPR of FISONS, 1995.

H. M. , , p.22, 1995.

, Acquisition by COLOPLAST of PORGÈS (MENTOR) (2006) Acquisition by RADIOPHARMA Partners of CISBIO (SCHERING, p.2005, 2006.

. Btg-vivasanté, J. Merger-of, E. Bio, and . Urgo, Acquisition by SOLVAY of FOURNIER Pharma, p.2004, 2005.

. Acquisition, P. Dolisos, and . Fabre-group, SANOFI-AVENTIS, Acquisition by SANOFI-SYNTHELABO of AVENTIS, 2004.

. Mcneil, Acquisition by STRAKAN of OTL PHARMA (2004) Acquisition by ZENEUS Pharma (ex-MEDEUS) of Opérations Européennes, p.2003, 2004.

, Acquisition by ZAMBON of Opérations Pharma de LAPHAL (2002) Divorce between BIOMÉRIEUX and PIERRE FABRE, ex-ALLIANCE BMPF (2002) Acquisition by IVAX of MSD GÉNÉRIQUES (2002) Acquisition by AXCAN PHARMA of LACTÉOL-BOUCARD (2002) Acquisition by PCAS of CRÉAPHARM (2002) Acquisition by EISAI of BIODIM, Acquisition by RANBAXY of RPG Biogalénique, french subsidiary of Génériques d'AVENTIS, p.1751, 2001.

, ???????? 1420 1428 1899 1666 1364 1927 ?? : Afssaps, 2001.

?. Afssaps and . ????, , 2001.

. Afssaps, Agence française de sécurité sanitaire des produits de santé) (2001) Rapport Annuel, 2001.

P. E. Barral, 26 ans de resultats de la recherche pharmaceutique dans le monde, 2002.

A. Blondeau and . Le-cherche-midi, Histoire des laboratories pharmaceutiques en France et de leurs drugs, 1992.

W. M. Cohen and D. A. Levinthal, Absorptive capacity: a new perspective on learning and innovation, Administrative Science Quarterly, 1990.

J. Dumoulin, Innovations pharmaceutiques et réglementation : le paradigme de l'explication, Economie Appliquée, tome XLVI, n°1, pp.101-126, 1994.

C. Edquist, Systems of innovation. Technologies, institutions and organizations, 1997.

Y. Ernst, Biotechnologies en France, 2001.

, Fédération Européenne des Associations de l'Industrie Pharmaceutique ( 2001 ) The Pharmaceutical industry in Figures

J. P. Juès, L'industrie pharmaceutique, 1998.

B. A. Lundvall, National systems of innovation: towards a theory of innovation and interactive learning, 1992.

A. Moreau, S. Rémont, and N. Zeinmann, L'industrie pharmaceutique en mutation, 2002.

, Research et Développement dans les entreprises, 1995.

R. Nelson and S. Winter, An evolutionary theory of economic change, 1982.

, ) The knowledge-based economy, OCDE, 1996.

, Science et technologie, Indicateurs, Economica, 2002.

D. Pilling, Is Europe losing the drug war? ?Journal of, Health care and society, vol.10, issue.1, 2000.

M. Ruffat, , 1996.

R. Scriban, Biotechnologie, Editions Lavoisier, p.4, 1993.

, SESSI (Service Statistiques Industrielles/Ministre Industrie, 1998.

, SESSI (Service Statistiques Industrielles/Ministre Industrie)(1998) L'innovation technologique en France, pp.1993-1997

, SNIP Pharmaceutiques: Revue mensuelle? Santé drug et industrie

, Syndicat National des Industries Pharmaceutiques, 1998.

, Livre blanc de la coopération en R&D entre l'industrie pharmaceutique et le secteur public, Syndicat National des Industries Pharmaceutiques, 1997.

, SNIP (Syndicat National des Industries Pharmaceutiques) (1996) Répertoire des métiers de l'industrie pharmaceutique

, Syndicat National des Industries Pharmaceutiques) (1997) Des éléments nouveaux de l'environnement R&D dans l, SNIP